Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Aptorum Group Ltd is a Hong Kong based pharmaceutical company currently in the preclinical stage, engaged in developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. The company is pursuing therapeutic and diagnostic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas. It also has projects focused on surgical robotics. The operating business segments are Therapeutics, and Non-Therapeutics segments. The company derives revenue from Healthcare service.
Hong Kong, Cayman Islands